Skip to main content
. 2013 Oct 25;2013(10):CD004785. doi: 10.1002/14651858.CD004785.pub5

Dworzack 1988.

Methods Double‐blind, ITT
Participants Volunteers
Interventions Ciprofloxacin 1 x 750 mg versus placebo
Outcomes Eradication, resistance developed, adverse effects
 Follow‐up: 21 days
Notes Main serogroups: B, Z
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Double‐blind
Incomplete outcome data (attrition bias) 
 All outcomes Low risk ITT
Selective reporting (reporting bias) Low risk No evidence
Other bias Low risk No evidence